JPH07501792A - １１β−置換された１４，１７−エタノエストラトリエン、この化合物の製造方法および医薬品としての使用 - Google Patents

１１β−置換された１４，１７−エタノエストラトリエン、この化合物の製造方法および医薬品としての使用

Info

Publication number
JPH07501792A
JPH07501792A JP5505804A JP50580493A JPH07501792A JP H07501792 A JPH07501792 A JP H07501792A JP 5505804 A JP5505804 A JP 5505804A JP 50580493 A JP50580493 A JP 50580493A JP H07501792 A JPH07501792 A JP H07501792A
Authority
JP
Japan
Prior art keywords
group
ethano
acid
amide
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5505804A
Other languages
English (en)
Japanese (ja)
Inventor
ボールマン，ロルフ
キュンツァー，ヘルマン
ムーン−ザイポルディ，ハンス−ペーター
西野　幸重
シュナイダー，マルティン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPH07501792A publication Critical patent/JPH07501792A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
JP5505804A 1991-09-24 1992-09-24 １１β−置換された１４，１７−エタノエストラトリエン、この化合物の製造方法および医薬品としての使用 Pending JPH07501792A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4132182.0 1991-09-24
DE4132182A DE4132182A1 (de) 1991-09-24 1991-09-24 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
PCT/EP1992/002210 WO1993006124A1 (de) 1991-09-24 1992-09-24 11β-SUBSTITUIERTE 14,17-ETHANOESTRATRIENE, VERFAHREN ZUR HERSTELLUNG DIESER VERBINDUNGEN, SOWIE IHRE VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN

Publications (1)

Publication Number Publication Date
JPH07501792A true JPH07501792A (ja) 1995-02-23

Family

ID=6441613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5505804A Pending JPH07501792A (ja) 1991-09-24 1992-09-24 １１β−置換された１４，１７−エタノエストラトリエン、この化合物の製造方法および医薬品としての使用

Country Status (10)

Country Link
US (1) US5502046A (enExample)
EP (2) EP0642529B1 (enExample)
JP (1) JPH07501792A (enExample)
AT (1) ATE146185T1 (enExample)
CA (1) CA2119780A1 (enExample)
DE (2) DE4132182A1 (enExample)
DK (1) DK0642529T3 (enExample)
ES (1) ES2097924T3 (enExample)
GR (1) GR3022692T3 (enExample)
WO (1) WO1993006124A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19724187A1 (de) * 1997-06-02 1998-12-03 Schering Ag 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln
HUP9802054A3 (en) * 1997-10-14 2001-02-28 Bayer Ag Process for producing 4,4,5,5,5-pentafluor-1-pentanol
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6198497B1 (en) 1998-06-03 2001-03-06 Hewlett-Packard Adjustment of a laser diode output power compensator
EP1131336B1 (en) * 1998-11-20 2002-08-28 Akzo Nobel N.V. Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process
GB0123961D0 (en) * 2001-10-05 2001-11-28 Astrazeneca Ab Process and intermediates
US20040235791A1 (en) * 2002-01-25 2004-11-25 Gruskin Elliott A. Scar reduction
DE102008061722A1 (de) 2008-12-12 2010-06-17 Saltigo Gmbh Verfahren zur Herstellung von Perfluoralkyl- oder Perfluoralkoxyalkanolen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE3925507A1 (de) * 1989-07-28 1991-01-31 Schering Ag 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
RU2087479C1 (ru) * 1989-11-29 1997-08-20 Шеринг Аг Эстратриены, содержащие мостик

Also Published As

Publication number Publication date
ATE146185T1 (de) 1996-12-15
US5502046A (en) 1996-03-26
DE4132182A1 (de) 1993-03-25
ES2097924T3 (es) 1997-04-16
CA2119780A1 (en) 1993-04-01
EP0546591A3 (enExample) 1994-03-09
GR3022692T3 (en) 1997-05-31
EP0642529A1 (de) 1995-03-15
EP0546591A2 (de) 1993-06-16
DE59207687D1 (de) 1997-01-23
DK0642529T3 (da) 1997-06-02
EP0642529B1 (de) 1996-12-11
WO1993006124A1 (de) 1993-04-01

Similar Documents

Publication Publication Date Title
US6958327B1 (en) 18 Norsteroids as selectively active estrogens
JP3814292B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体、これらの製造方法及びこれら化合物を含有する製薬組成物
US20080132476A1 (en) Substituted estratrienes as selectively active estrogens
WO1998027106A1 (en) Aminosterol ester compounds
WO2000063228A1 (en) Ent-steroids as selectively active estrogens
EA001577B1 (ru) 7альфа-(кси-аминоалкил)эстратриены, способ их получения, фармацевтические препараты, содержащие эти 7альфа-(кси-аминоалкил) эстратриены, и их применение для изготовления лекарственных средств
EP0500899B1 (en) Novel 15,16-seco-19-nor progestins
JPH07501792A (ja) １１β−置換された１４，１７−エタノエストラトリエン、この化合物の製造方法および医薬品としての使用
JP2000510861A (ja) ７α―（５―メチルアミノペンチル）―エストラトリエン、その製造方法、この７α―（５―メチルアミノペンチル）―エストラトリエンを含有する医薬製剤、並びに医薬を製造するためのその使用
JP2002536455A (ja) 選択的エストロゲンとしての１６−ヒドロキシエストラトリエン
CA2171740C (en) 0rally active derivatives of 1,3,5(10)-estratriene
JP2003513102A (ja) 選択的な作用を有するエストロゲンとしての１８−ノル−ステロイド
JPH0515720B2 (enExample)
EA008442B1 (ru) 9α-ЗАМЕЩЁННЫЕ ЭСТРАТРИЕНЫ В КАЧЕСТВЕ ЭСТРОГЕНОВ ИЗБИРАТЕЛЬНОГО ДЕЙСТВИЯ
JPH03218393A (ja) １４，１７α―エテノ―および―エタノエストラトリエン、その製造方法およびこれを含有するエストロゲンが誘因のまたはエストロゲンから誘導される疾患の治療のための医薬品
US6596713B1 (en) Steroid esters and amides, process for their production and their pharmaceutical use
US20060270845A1 (en) 16-Hydroxyestratrienes as selectively active estrogens
US5529993A (en) 14α, 17α-ethano-16α-hydroxy-estratrienes
US20090029957A1 (en) 8-beta-substituted estratrienes as selectively active estrogens
US20050282791A1 (en) 18-nor steroids as selectively active estrogens
AU2004201405A1 (en) Ent-Steroids as selectively active estrogens
JPH06504780A (ja) １４，１６β−エタノ−１５β，１６↑１−シクロ−１４β−エストラ−１，３，５（１０）−トリエン
JPS63255296A (ja) エストラジオ−ル誘導体